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While diet-induced obesity has been exclusively
attributed to increased caloric intake from fat,
animals fed a high-fat diet (HFD) ad libitum (ad lib)
eat frequently throughout day and night, disrupting
the normal feeding cycle. To test whether obesity
and metabolic diseases result from HFD or disrup-
tion of metabolic cycles, we subjected mice to either
ad lib or time-restricted feeding (tRF) of a HFD for 8 hr
per day. Mice under tRF consume equivalent calories
from HFD as those with ad lib access yet are pro-
tected against obesity, hyperinsulinemia, hepatic
steatosis, and inflammation and have improved
motor coordination. The tRF regimen improved
CREB, mTOR, and AMPK pathway function and
oscillations of the circadian clock and their target
genes’ expression. These changes in catabolic and
anabolic pathways altered liver metabolome and
improved nutrient utilization and energy expenditure.
We demonstrate in mice that tRF regimen is a non-
pharmacological strategy against obesity and asso-
ciated diseases.
INTRODUCTION
In order to adapt to the daily cycles of nutrient availability, energy
metabolism in animals has evolved to be cyclical. These meta-
bolic cycles arise from cell-autonomous circadian rhythms
and the feeding-fasting cycle, which drive genomic programs
(Vollmers et al., 2009). At the molecular level, cell-autonomous
circadian rhythms are based on interlocked negative feedback
circuits in which BMAL1, CLOCK, NPAS2, and ROR proteins
act as transcriptional activators and PER, CRY, and REV-ERB
function as inhibitors to produce 24 hr self-sustained rhythmic
transcription of their own and target genes (reviewed in Reddy
and O’Neill, 2010).
Feeding and fasting also drive daily rhythms in the activities of
key regulators of nutrient homeostasis including AMPK, CREB,848 Cell Metabolism 15, 848–860, June 6, 2012 ª2012 Elsevier Inc.and AKT (Vollmers et al., 2009). There is extensive coupling
between circadian oscillator components and the feeding-
fasting-driven metabolic regulators. This coupling leads to coor-
dinated oscillations at the transcript level and in the activities of
a large number of neuroendocrine, signaling, and metabolic
pathways that temporally link discordant cellular processes.
Perturbation of circadian oscillator components leads to
obesity and diabetes, illustrating the importance of this intercon-
nection. Genetic mousemodels carrying either tissue-specific or
whole-body loss-of-function or hypomorphic alleles of circadian
oscillator components develop impaired glucose tolerance and
signs of metabolic disease. Conversely, disruption of diurnal
rhythms is commonly found in animal models of diabetes and
obesity lacking specific metabolic regulators (reviewed in Bass
and Takahashi, 2010). However, circadian oscillator compo-
nents and metabolic regulators also control a large number of
downstream effectors which do not exhibit any overt rhythms
in expression (Cho et al., 2012; Feng et al., 2011; Rey et al.,
2011). A number of mouse genetic models carrying whole-
body- or tissue-specific perturbation of circadian oscillators
(Cho et al., 2012; Kornmann et al., 2007; Lamia et al., 2008;
Marcheva et al., 2010; Preitner et al., 2002; Turek et al., 2005)
or key metabolic regulators (Andreelli et al., 2006; Herzig et al.,
2001, 2003; Shaw et al., 2005) exhibit no profound defect in
the overt rhythms in activity or feeding under normal light:dark
cycle yet exhibit metabolic dysfunctions. Therefore, genetic
models are inconclusive in addressing whether metabolic oscil-
lations are necessary and sufficient for preventing metabolic
diseases under nutritional challenge such as one posed by
a high-fat diet (HFD).
To test whether robust metabolic cycles can protect against
nutritional challenges that predispose to obesity, we adopted
a widely used rodent model of diet-induced obesity. Mice fed
aHFDad libitum (ad lib) developobesity, diabetes, andmetabolic
syndrome. However, they also exhibit dampened feeding and
circadian rhythms (Kohsaka et al., 2007). Limiting access to
HFD during day or night for up to 6 weeks shows some improve-
ment in body weight regulation (Arble et al., 2009; Bray et al.,
2010). However, since body weight and metabolic diseases are
not always correlated (Ruderman et al., 1998; Wang et al.,
2010), it is unclear whether time-restricted feeding (tRF) without
changing caloric intake prevents metabolic diseases.
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composition or one with high-fat content under two food-access
paradigms: ad lib or time-restricted access for more than
100 days. tRF improved metabolic and physiologic rhythms,
and protected the mice from the adverse effects of a HFD. The
time-restricted high-fat-fed mice showed significantly increased
thermogenesis and improved rhythms in nutrient utilization,
leading to reduced adiposity and liver steatosis, normal glucose
tolerance, reduced serum cholesterol, increased bile acid
production, and improved motor function.
RESULTS
Time-Restricted Feeding Improves Overt Rhythms and
Attenuates Body Weight Gain
To test whether a distinct tRF regimen can prevent diet-induced
obesity, we subjected 12-week-old male C57BL/6J mice to HFD
(61% energy from fat) or normal chow (NC; 13% fat) under either
ad lib or time-restricted access to food during their natural
nocturnal feeding time (Figure 1A). Mice fed NC under an ad lib
regimen (NA) displayed diurnal rhythms in their food intake and
whole-body respiratory exchange ratio (RER) (Figures 1B and
1C). Food intake and RER exhibited a nocturnal increase, reflec-
tive of feeding and subsequent carbohydrate utilization, and
declined during the day, consistent with lipid oxidation during
fasting. Mice fed a HFD under an ad lib regimen (FA) displayed
dampened diurnal rhythms in food intake and RER. In contrast,
mice fed NC or HFD under a tRF regimen (NT and FT) improved
diurnal rhythms in their RER compared to their ad lib-fed
counterparts, with higher RER during feeding and reduced
RER during fasting, indicative of increased glycolysis and fat
oxidation, respectively (Figure 1C). Although all four groups of
mice showed overall comparable nocturnal activity, the mice
on tRF regimen (NT and FT) showed increased activity and
increased energy expenditure toward the end of the night
(Figures 1D–1F). The average daily energy intake for individual
mice in all four groups was equivalent throughout 18 weeks of
the experiment (Figures 1G and 1H). When normalized for
body weight, the mice on tRF paradigms, in fact, showed
increased energy intake/unit body weight toward the end of
the experiment (Figure 1I). Most remarkably, despite equivalent
energy intake from the same nutrient source, FT mice were pro-
tected against excessive body weight gain that afflicted FA mice
(Figures 1J and 1K and see Figure S1 online), suggesting that the
temporal feeding pattern reprograms themolecular mechanisms
of energy metabolism and body weight regulation.
Temporal Feeding Pattern Shapes Rhythms in CREB,
mTOR, and AMPK Activities and in the Circadian
Oscillator
A HFD fed under an ad lib regimen perturbs metabolic regula-
tors, including CREB, mTOR, and AMPK, and contributes to
metabolic diseases (Altarejos and Montminy, 2011; Inoki et al.,
2011). Hepatic CREB phosphorylation is elevated during fasting,
consistent with the role of active pCREB in gluconeogenesis
(Herzig et al., 2001), while insulin and mTOR-stimulated pS6
levels (Um et al., 2006) are elevated during feeding. In NA
mice, the diurnal rhythm in food intake (Figure 1B) induced
hepatic CREB phosphorylation during daytime fasting andCincreased pS6 levels during nighttime feeding (Figures 2A and
2B). In FA mice, the perturbed circadian feeding pattern blunted
pCREB and pS6 oscillations and led to constitutively elevated
pCREB and reduced pS6 levels. In contrast, in the FT mice,
the tRF imposed a diurnal rhythm in food intake, thereby
restoring the daytime peak in pCREB and nighttime peak in
pS6. The diurnal rhythm in food intake and associated daily fast-
ing period under the FT paradigm increased the hepatic AMP
levels relative to that seen in the FA paradigm (Figure 2C).
Upon allosteric activation by AMP, AMPK, a master regulator
of energy metabolism, phosphorylates and deactivates one of
the rate-limiting enzymes of fatty acid oxidation, acetyl CoA
carboxylase (ACC) (Davies et al., 1990). Thus, increased AMP
and phospho-ACC (pACC, relative to total ACC) (Figures 2C
and 2D, Figures S2A–S2C, and Table S1) in the livers of FT
mice reflected increased AMPK activity relative to the livers of
FA mice.
During fasting, AMPK phosphorylates a circadian repressor
CRY (Lamia et al., 2009) and targets it for subsequent degrada-
tion, thus preventing it from repressing CLOCK:BMAL1 target
genes, such as Rev-erba, Per, and Cry. During feeding, mTOR
activity indirectly modulates Per expression (Giebultowicz and
Kapahi, 2010). Under the FA regimen, perturbed total and/or
diurnal change in active CREB, mTOR, and AMPK reduced the
mRNA levels and/or dampened the oscillations of circadian
clock components (Per1, Per2, Cry1, Bmal1, Clock, Rora,
Rev-erba, and an immediate output target, Dbp) in the liver
(Figure 2E and Figure S2D). Under the FT regimen, the imposed
feeding rhythms resulted in improved oscillations of circadian
clock components in the liver, with an increase in the peak to
trough ratio of mRNA levels. NA mice show a robust feeding
rhythm and clear oscillations in clock gene expression, which
is moderately improved by feeding consolidation in the NT mice.
Hepatic Glucose Metabolism Is Improved under
Time-Restricted Feeding
Coordination among circadian oscillator components and meta-
bolic regulators helps maintain glucose homeostasis and
anabolic metabolism in the liver. Rhythmic Cry expression and
pCREB oscillation synergistically suppress gluconeogenic
gene expression (Vollmers et al., 2009; Zhang et al., 2010).
Accordingly, in the livers of FT mice, improved CRY expression
and suppressed nocturnal pCREB (Figures 2A and 2E) reduced
the mRNA levels of gluconeogenic CREB target genes Pyruvate
carboxylase (Pcx) and Glucose-6-phosphatase (G6pc) (Figures
3A and 3B), which encode enzymes that mediate the committing
step in gluconeogenesis. With reduced Pcx and G6pc gene
expression, pyruvate is likely used in the TCA cycle, since the
levels of several TCA cycle intermediates (e.g., malate, fumarate,
and citrate) are increased in the livers of FT mice (Figure 3C and
Table S1). In parallel, reduced dephosphorylation of glucose-
6-phosphate (G6-P) contributed to lowering blood glucose by
decreasing the release of free glucose. The increased G6-P in
the FT liver (Figure 3C) is likely diverted to the pentose phosphate
cycle (PPC).
mTOR induces the expression of glucose-6-phosphate dehy-
drogenase (G6pdx) (Duvel et al., 2010), whose protein product is
the rate-limiting enzyme of the PPC and is activated by accumu-
lation of its substrate G6-P. In turn, the PPC is a major source ofell Metabolism 15, 848–860, June 6, 2012 ª2012 Elsevier Inc. 849
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Figure 1. Time of Feeding Shapes Diurnal Pattern of Whole-Body Metabolism and Influences Body Weight Gain
(A) Schematic outline of the four feeding regimens used in this study. Time-restricted-fed mice were allowed access to food from ZT13 through ZT21. Food
availability is indicated by light beige boxes.
(B–E) Shown are (B) food ingested, (C) respiratory exchange ratio (CO2 exhaled/O2 inhaled), (D) average activity, and (E) whole-body energy expenditure as
measured by volume of O2 consumed in 2 hr bins plotted against time (+SEM, n = 4 mice). Since the high-fat diet (HFD) is energy rich (5.51 Kcal/g), the mice on
HFD consume an amount of energy equivalent to that of the mice on normal chow (NC) (3.36 Kcal/g).
(F) Area under the curve analyses of energy expenditure (from Figure 1E) (+SEM, n = 4, *p < 0.05). Given the differences in body composition, metabolic activities
in different organs, and heterogeneity of substrate uses in different groups ofmice, both food intake and energy expenditureswere expressed relative to individual
animal or unit body weight.
(G and H) (G) Cumulative average energy intake or (H) average daily energy intake (+SEM, n = 24 over 17 weeks) by individual mice on NC or HFD is not
significantly different (n.s., p > 0.05) under ad lib or tRF paradigm. The near-equivalent average energy intake from NC and HFD is not different from several
published studies. Voluntary energy intake is often independent of dietary fat content both in rodents and in human twins (examples include but are not limited to
Bray et al., 2010; Fujisaka et al., 2011; Hosooka et al., 2008; Kennedy et al., 2007; Lin et al., 2000; Saltzman et al., 1997; Samuel et al., 2004), and these studies
also show that irrespective of caloric intake, voluntary ingestion of HFD predisposes to obesity, diabetes, and related diseases. The higher proportion of energy
intake from fat is usually considered the cause for diet-induced obesity in these studies.
(I) Average energy intake (+SEM) normalized to unit body weight shows no difference at the beginning of the experiment. In the subsequent weeks with gradual
increase in body weight, this value progressively declines. By the end of 16–18 weeks, mice on tRF consume more energy/unit body weight than the ad lib
counterparts.
(J) Representative FT mouse was remarkably leaner than the FA mouse.
(K) Average body weight (+SEM, n = 20–32 mice). Also see Figure S1.
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Figure 2. Time-Restricted Feeding Improves Diurnal Rhythms in Metabolic Regulators and the Circadian Oscillator
(A and B) Representative immunoblots and densitometry quantification of the immunoblots (average [+SEM, n = 3] during feeding and fasting in the tRF
mice, which coincide with night and day, respectively) for (A) transcriptionally active phospho-Ser133-CREB (pCREB) and (B) phospho-S6 (pS6) in the
mouse liver.
(C) Whisker plot showing the AMP level in the liver of FTmice is significantly higher than that in FAmice. Error bars denote maximum andminimum of distribution.
(D) Proportion of phospho-ACC (pACC) relative to total ACC from mouse liver (also see Figure S2).
(E) Double-plotted average (+SEM, n = 4) mRNA levels of circadian oscillator components Per2, Bmal1, Rev-erba, Cry1, and additional clock components
(Figure S2D) in liver at different times of the day. Transcript levels were measured by qRT-PCR and normalized to Gapdh mRNA levels. Broken line separates
double plotted data. Also see Figure S2.
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Time-Restricted Feeding Counters Metabolic DiseaseNADPH, which reduces glutathione. In the livers of mice under
tRF, induced expression of G6pdx along with elevated G6-P
led to increased activity of the PPC as measured by higher levels
of PPC intermediates and of reduced glutathione (Figures 3D
and 3E and Figure S3).
The pentose sugars of PPC and intermediates of TCA cycle
are substrates for both de novo and salvage pathways of nucle-
otide biosynthesis. Several genes encoding enzymes of purine
and pyrimidine biosynthesis and nucleotide salvage pathways
are the direct targets of the circadian activator BMAL1 (Uridine
monophosphate synthase [Umps] and Thymidine kinase 1
[Tk1]) and/or exhibit rhythmic expression patterns (phosphoribo-
sylpyrophosphate synthetase [Prps-1,-2], phosphoribosyl pyro-
phosphate amidotransferase [Ppat] and Carbamoyl phosphate
synthetase/aspartate transcarbamylase/dihydroorotase [Cad])
(Hughes et al., 2009; Nakahata et al., 2009; Ramsey et al.,
2009; Rey et al., 2011; Vollmers et al., 2009). In the FT livers,
increased Bmal1 mRNA led to a parallel increase in the mRNA
levels of Umps and Tk1 as well as elevated levels of both purineCand pyrimidine metabolites (Figures 3F–3H, Figures S3 and
S4A). These coordinated changes in gene expression and
metabolites show that the tRF regimen temporally reprograms
glucose metabolism away from gluconeogenesis toward glycol-
ysis, reduced glutathione, and anabolic pathways. Accordingly,
FT mice did not display the hallmarks associated with glucose
intolerance found in diet-induced obesity, instead showing
glucose tolerance and insulin levels comparable to the control
NA mice (Figures 3I and 3J). The overall improvement in meta-
bolic state also paralleled improved motor coordination in the
mice under tRF paradigms (Figure 3K).
The Temporal Pattern of Feeding Determines Lipid
Homeostasis
The circadian oscillator components interact with metabolic
regulators to maintain lipid homeostasis. In the livers of FT mice,
increased levels of the transcriptional repressor Rev-erba
(Figure 2E) led to reduced expression of its direct target and
a key lipogenic gene, fatty acid synthase (Fasn) (Cho et al.,ell Metabolism 15, 848–860, June 6, 2012 ª2012 Elsevier Inc. 851
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Figure 3. Time-Restricted Feeding Alters Glucose Metabolism and Restores Normal Glucose Tolerance
(A–C) qRT-PCR estimates of mRNA levels of gluconeogenic CREB targets (A) Pcx and (B) G6pc show reduced expression during feeding in the liver of FT mice.
This is accompanied by (C) increased levels of G6-P and TCA cycle metabolites malate, fumarate, and citrate.
(D–H) (D) Elevated mRNA level of G6pdx in the livers of FT mice correlated with (E) a rise in pentose phosphate cycle (PPC) metabolites ribulose-5-P, ribose 5-P,
fructose 6-P, and sedoheptulose 7-P and higher levels of reduced glutathione. tRF regimen also improved the oscillation of (F) Umps and (G) Tk1mRNA in liver
and consequently of (H) nucleotide metabolites (also see Figures S3 and S4A) which are produced from PPC intermediates.
(I) IPGTT shows normal glucose tolerance in FT mice. Average blood glucose levels (+SEM, n = 6 mice) in overnight fasted mice before and after glucose infusion
are shown.
(J) Levels of blood insulin after overnight fasting or 1 hr after glucose infusion.
(K) Time spent (average +SEM, n = 6, *p < 0.05) on an accelerating rotarod.
In (C), (E), and (H), error bars denote maximum and minimum of distribution with extreme data points marked (o).
Cell Metabolism
Time-Restricted Feeding Counters Metabolic Disease2012) (Figure 4A). Reduced Fasn mRNA levels (Figure 4A) and
increased relative pACC levels (Figure 2D) are known to
contribute to a decline in the level of several long-chain free852 Cell Metabolism 15, 848–860, June 6, 2012 ª2012 Elsevier Inc.fatty acids (Harwood, 2004), including myristate and palmitate
(Figure 4B and Table S1). In parallel, increased Per2 expression
in FT liver (Figure 2E) acts as an inhibitor of already-reduced levels
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Figure 4. Time-Restricted Feeding Alters Fatty Acid Metabolism and Prevents Obesity and Liver Pathology
(A and B) (A) Reduced hepatic mRNA levels of REV-ERBa target gene Fasn in the livers of FT mice contribute to (B) the reduction in free fatty acids myristate and
palmitate.
(C–G) Reduced mRNA levels of (C) Pparg, (D) Scd1, and (E) Elovl5 in the liver of FT mice (also see Figure S3) accompanied reduced levels of several unsaturated
fatty acids including (F) oleate, palmitoleate, eicosenoate, and vaccinate (also see Figure S4B). Reduced malonyl-carnitine, increased BHBA (see also
Figure S4B), and (G) increased Lipc mRNA are indicative of increased b-oxidation.
(H) Body composition analyses by MRI illustrate that tRF prevents excessive whole-body fat accumulation in mice fed HF diet. Average weights of fat, lean, and
remaining body mass are shown.
(I) Increased levels of leptin after overnight fasting () and after glucose administration (+) indicative of increased adipose tissue in FA mice are absent in the
FT mice.
(J and K) (J) tRF also prevents enlarged liver and (K) liver damage assessed by increased serum ALT.
In (B) and (F), error bars denote maximum and minimum of distribution with extreme data points marked (o).
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Time-Restricted Feeding Counters Metabolic Diseaseof Pparg (Figure 4C) (Grimaldi et al., 2010), further attenuating
PPARg-driven lipogenic gene expression. Repression of the
PPARg target gene Stearoyl coA desaturase1 (Scd1) (Figure 4D),
which encodes an enzyme mediating fatty acid desaturation,
along with the reduced mRNA levels of the unsaturated fatty
acid elongase Elovl5 (Figure 4E and Figure S3) coincides with
>50% decline in several unsaturated fatty acids, including oleate
(18:1n9), palmitoleate (16:1n7), vaccenate (18:1n7), and eicose-
noate (20:1n9 or 11) (Figure 4F and Figure S4B). Altogether, we
observed reduced fatty acid synthesis, elongation, and desatura-
tion in the livers of FT mice compared to those of the FA mice.
Fatty acid synthesis inhibits mitochondrial b-oxidation.
Malonyl-CoA, a product of ACC activity in the first step of fatty
acid synthesis, allosterically inhibits mitochondrial carnitine pal-
mitoyltransferase (CPT). CPT is essential for the transit of long-
chain fatty acids and acylcarnitine esters into the mitochondria
for b-oxidation. Increased hepatic malonylcarnitine levels in FACmice, but not in FTmice (FigureS4B), are indicative of the specific
disruption of fatty acid oxidation causedby impaired entry of fatty
acids into the mitochondria. Conversely, increased hepatic
lipase (Lipc) expression (Figure 4G) alongwith 3-hydroxybutyrate
(BHBA) (FigureS4B), oneof the endproducts ofb-oxidation, in FT
mice relative to FA mice indicated that tRF enhanced lipolysis
and b-oxidation, further contributing to reduction in liver free fatty
acids.
Time-Restricted Feeding Prevents Excessive Body
Weight Gain, Hepatosteatosis, and Liver Damage
Among mice fed NC, the tRF regimen resulted in moderately
lower weight (NT, 30.5 ± 0.4 g; mean ± SEM, n = 24) than the
ad lib regimen (NA, 32.6 ± 0.4 g) (Figure 1K). In contrast, tRF
remarkably reduced obesity in mice fed a HFD. Mice with ad
lib access to HFD (FA) attained an average body weight of
47.4 g ± 0.7 g by 18 weeks in the feeding regimen (Figure 1K),ell Metabolism 15, 848–860, June 6, 2012 ª2012 Elsevier Inc. 853
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Time-Restricted Feeding Counters Metabolic Diseasewhile FT mice weighed 28% less (34.2 ± 0.6 g) and were compa-
rable to the NA group. Most of the extra body weight in the FA
mice was due to increased adiposity (Figure 4H). FA mice
showed 70% more fat deposits than those in the FT mice (FA
18.0 ± 1.03 g and FT 4.3 ± 1.23 g, p < 0.05). Consequently, hyper-
leptinemia associated with diet-induced obesity in FA mice was
absent in FT mice (Figure 4I).
FT mice were also protected from the hepatomegaly and
elevated serum alanine aminotransferase (ALT) levels that are
associated with obesity-induced hepatic steatosis (Figures 4J
and 4K). To further characterize the pathologic state and steato-
sis of the liver in these four groups, we used a Brunting scoring
system under blinded conditions. Tissue samples from the FT
mice had significantly less hepatic steatosis compared to those
from the FA mice (Figures 5A and 5B). In addition, volume anal-
yses of serial block-face scanning electron microscope images
of the liver samples revealed that livers from the FT mice did
not have the profound increase in intracellular fat deposits,
reduced mitochondrial density, and reduced endoplasmic retic-
ulum that were characteristic of the liver samples from the FA
mice (Figures 5C and 5D and Table S2).
The liver disease in FAmicewas associatedwith an increase in
markers of inflammation. The increased pool of free fatty acids in
the livers of FA mice included proinflammatory long-chain n-6
fatty acids dihomo-linoleate (20:2n6) and arachidonate (20:4n6)
(Figure S4C). Oxidation of arachidonate and linoleic acid in an
oxidative environment marked by decreased glutathione in the
livers of the FA mice further increased the levels of proinflamma-
tory eicosanoids: 15-hydroxyeicosatetraenoic acid (HETE),
5-HETE, and 13-HODE. In contrast, the suppressed lipogenic
program along with a glutathione-enriched cellular environment
in the livers of the FT mice attenuated the levels of proinflamma-
tory lipids (Figure S4C).
Additional gene expression signatures often associated with
hepatic inflammation and fatty liver disease (Figure 5E and
Figure S5) were either reversed or attenuated under a tRF
regimen. Changes in hepatic expression of nuclear hormone
receptors Rara, Rxra, Lxra, and Lxrb, a characteristic of diet-
induced obesity (Kohsaka et al., 2007), are prevented upon
tRF. Increased expression of several genes encoding key
enzymes for lipid metabolism, including Crat (cytoplasmic carni-
tine acyltransferase), Me1 (malic enzyme producing reducing
NADPH for fat synthesis), and Mogat1 (monoacylglycerol
O-acyltransferase 1) in the FA mice return to NC-fed levels
in the FT group. Similarly, higher expression of lipid droplet-
associated and lipolysis inhibitor gene Cidec (Puri et al., 2007),
triglyceride storage-associated protein CD36 (Koonen et al.,
2007), and plasma triglyceride marker ApoA4 (Talmud et al.,
2002) in the liver of FA mice are reduced in the FT mice. The
expression of Cdkn1a (p21), a cell cycle regulator, and of Lgals1
(Galectin-1), a hepatocellular carcinoma and metastasis marker
(Camby et al., 2006), is elevated in the FA group and reduced
under tRF. High-fat ad lib feeding (FA) reduced expression of
antidiabetic gene Igfbp2 (Hedbacker et al., 2010), while tRF
elevated expression irrespective of the nutrient source. Addition-
ally, Fabp1 (Fatty acid binding protein 1), which binds to and
clears potentially toxic unesterified long-chain fatty acids from
the cytoplasm (Atshaves et al., 2010), exhibits a moderate
increase in expression in the liver of FT mice.854 Cell Metabolism 15, 848–860, June 6, 2012 ª2012 Elsevier Inc.Time-Restricted Feeding Raises Bile Acid Production,
Improves Adipose Tissue Homeostasis, and Alleviates
Inflammation
Hepatic fatty acid metabolism contributes to cholesterol and bile
acid homeostasis. Both the diurnal rhythms in food intake and the
clock componentRev-erbaareknown toparticipate in thediurnal
production of cholesterol and bile acids through transcriptional
regulation of the lipid homeostasis regulatorSrebp1c and several
rate-limiting enzymes including Hmgcs2 and Cyp7a1 (Cho et al.,
2012; Le Martelot et al., 2009). Distinct feeding rhythms along
with improved Rev-erba rhythms in the livers of the FT regimen
mice altered expression of Srebp1c, Hmgcs2, and Cyp7a1
(Figures 6A and 6B, Figures S3 and S5). Increased peak levels
of Cyp7a1 mRNA, which encodes the rate-limiting step in bile
acid production from cholesterol, elevated hepatic bile acids
and contributed to a decrease in serum cholesterol levels in the
FT mice (Figures 6C and 6D, Figure S6, and Table S1). Although
the liver is efficient in reabsorbing bile acids, increased postpran-
dial hepatic bile acids spill over into circulation and raise energy
expenditure in brown adipose tissue (BAT) by inducing expres-
sion of the uncoupling proteins (Watanabe et al., 2006). Indeed,
in BAT derived from FT mice, we observed increased and
rhythmic UCP expression (Figure 6E) which paralleled nighttime
energy expenditure as measured by whole-body oxygen use
(Figures 1E and 1F), aswell as improved circadian oscillator func-
tion and increased PPARa expression (Figure 6E).
Elevated b-oxidation and reduced fatty acid synthesis in the
liver coupled with increased BAT energy expenditure observed
in the FT mice prevented the adipocyte hypertrophy common
to BAT and white adipose tissue (WAT) derived from the FA
mice (Figures 6F and 6G). Furthermore, inflammation marked
by extensive infiltration ofmacrophages and expression of proin-
flammatory genes including TNFa, IL6, and CXCL2 that are
generally found in the WAT of the FA mice, were attenuated in
the FT mice (Figure 6H). Even in mice fed a normal diet, tRF
reduced the expression of inflammatory cytokines in the WAT.
In summary, the tRF paradigm affected multiple tissues,
improved whole-body energy homeostasis, and reduced
inflammation.
DISCUSSION
Obesity is amajor health challenge inmany developed countries,
reaching global pandemic proportions (Finucane et al., 2011).
The prevalence of obesity has risen unabated for the last four
decades, currently affecting 35.5% of the population of United
States and projected to affect as much as 50% of the population
in another four decades (King, 2011). Themorbidity andmortality
of its associated metabolic diseases, as well as its economic
impact (Hammond and Levine, 2010), has made finding treat-
ments for obesity an imperative of multiple national health
agencies. Lifestyle modification is the first-line intervention in
the treatment of obesity due to ease of access and lower cost
over pharmacotherapy or surgery (McTigue et al., 2003). The
focus of currently recommended lifestyle modification has
been altering nutrition. In a murine model, here we introduce
a lifestyle intervention that can prevent obesity as well as its
associated metabolic disorders by preserving natural feeding
rhythms without altering nutrition intake.
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Figure 5. Time-Restricted Feeding Prevents Liver Diseases
(A) Representative histology (upper panel, H&E, scale bars, 200 mm; and lower panel, Sirius red, scale bars, 200 mm) of the liver. Steatohepatitis was scored by
a histopathologist who was blinded to the source condition of each sample using a semiquantitative method derived from Brunt et al. (Brunt et al., 2004)
measuring the degree of steatosis (0–3), ballooning degeneration (0–2), lobular (0–3) and portal (0–2) inflammation, and fibrosis (0–4).
(B) Average steatosis score (+SEM, n = 4 mice) of liver sections.
(C) Representative scanning electron microscope image of a liver from FA mice shows large lipid droplets and vacuoles that are reduced in FT liver. Scale
bar, 1 mm.
(D) Measurement of several volume fractions shows FT regimen prevents the decline in density of mitochondria and ER under ad lib HF diet (FA). Measurements
are from a volume rendering obtained from serial block-face images of the liver. See also Table S2.
(E) Gene expression signature of diet-induced obesity in the mouse liver is attenuated by tRF. Average expression (+SEM) from eight different time points
(Figure S2A) are shown in bar graphs. Significant differences between FA and FT (p < 0.05) were found. Temporal expression profiles of these genes are shown in
Figure S5.
Cell Metabolism
Time-Restricted Feeding Counters Metabolic DiseaseAlthough it has long been assumed that the cause of adiposity
associated with mouse models of diet-induced obesity is nutri-
tional, there is an emerging suggestion that the temporal
spreading of calorie intake could be contributing as well. Under
ad lib access to food, a HFD blunts the diurnal feeding rhythms
more severely than a standard diet (Figure 1B). Therefore, miceCfed HFD ad lib have a short fasting period and a long feeding
window. This feeding pattern perturbs metabolic pathways en-
trained by both circadian and feeding rhythms. The temporal
disruption in cellular metabolic processes, in combination with
the nutrient quality, predisposes the organism to obesity and
metabolic diseases.ell Metabolism 15, 848–860, June 6, 2012 ª2012 Elsevier Inc. 855
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Figure 6. Time-Restricted Feeding Modulates Bile Acid Metabolism, Energy Expenditure, and Inflammation
(A–D) tRF regimen (A) suppressed the expression ofHmgcs2 and (B) increased the expression ofCyp7a1 in the liver, which accompanied (C) a reduction in serum
cholesterol and (D) an increase in hepatic bile acids. Relative levels of representative bile acids are shown (also see Figure S6). Error bars denote maximum and
minimum of distribution with extreme data points marked (o).
(E–H) (E) qRT-PCR measurements of relative mRNA levels of Bmal1, Dbp, and Ppara show robust circadian oscillation in the BAT of FT mice (also see Figure S3
for NA and NT gene expression). Increased expression of UCP1-3 during the late night correlates with increased energy expenditure in FT mice (Figure 1).
H&E-stained sections of (F) BAT or (G) WAT show that the adipocyte hypertrophy seen in FA mice is prevented in the FT mice. Scale bar, 50 mm. Arrows indicate
infiltrating cells that are most likely macrophages. Reduction in infiltrating macrophages also correlates with a reduction in (H) the mRNA levels of several
proinflammatory cytokines in the WAT of FT mice. Average (+SEM, n = 8) mRNA levels of proinflammatory cytokines TNFa, CXCL2, IL6, and IL1 in the WAT are
reduced under the tRF paradigm.
Cell Metabolism
Time-Restricted Feeding Counters Metabolic DiseaseThe tRF regimen entrained the circadian clock and metabolic
regulators to fixed feeding times and prevented high-fat-diet-
induced disruption of the normal cellular metabolic program.
Compared to their NC counterparts, the beneficial effect of tRF
on the gene expression (Figures 2–6, Figures S3 and S5) and
metabolic signatures is more pronounced in mice fed a HFD.
Liver metabolome analyses detected 324 named metabolites
common to all four groups of mice, of which 240 (74%) changed
between at least one pair of feeding regimen (Figures 7A and 7B,
Table S1, and http://metabolites.salk.edu/), thus highlighting
that both nutrient quality and the daily feeding pattern are impor-
tant determinants of the liver metabolic homeostasis. Among
mice fed a standard diet, time of food access changed the over-
all levels of 56 metabolites, while 123 metabolites changed
between mice under FA and FT regimen. Both the average levels856 Cell Metabolism 15, 848–860, June 6, 2012 ª2012 Elsevier Inc.and diurnal oscillations of these metabolites are defined by the
time of feeding (Figures 7C–7E and Figure S7).
Implicit in our findings is that the control of energy metabolism
is a finely tuned process that involves an intricate network of
signaling pathways and transcriptional effectors, including
nutrient-sensing mechanisms and the circadian system. tRF
acted on these interwoven networks and moved their state
toward that of a normal feeding rhythm. In addition to nutrient
metabolism, pathways regulating steady-state levels of signaling
molecules and cofactors in the liver such as bile acids, sterols,
riboflavin, heme, and coenzyme-A (Figure 7E, Figure S7, and
Table S1) are also affected by the time of feeding. These
signaling molecules and cofactors likely affect functions of
multiple other organs, partly explaining how feeding rhythms
can indirectly have systemic consequences. The beneficial
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Figure 7. Time of Feeding Exerts a Profound Effect on Liver Metabolites in Mice on a High-Fat Diet
(A) Heatmap rendering of normalized levels of 324 liver metabolites at eight different time points in the liver of NA, NT, FA, and FT groups of mice. The metabolites
were clustered by hierarchical clustering.
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Cell Metabolism
Time-Restricted Feeding Counters Metabolic Diseaseeffects of tRF were also evident in mice fed NC, implying that tRF
might improve metabolism under diverse nutritional challenges.
Although a number of clinical studies have shown that the
perturbation of light:dark or sleep:wake cycle (e.g., shiftwork)
has adverse metabolic consequences in humans, there is very
little information on the perturbation of eating rhythms in the
participants of these studies. Hence, the contribution of frequent
feeding and reduced daily fasting period to obesity, type 2 dia-
betes, and other adult-onset metabolic diseases is unclear.
Current public health surveys on human nutrition focus on the
quality of nutrition and quantity of food consumption with no
evidence-based method in place to monitor temporal pattern
of food intake. More studies are necessary to define the relation-
ship between temporal eating and obesity in humans. The results
presented in our study with mice suggest that tRF could be
a nonpharmacological intervention in humans that could prevent
obesity and its associated metabolic disorders.EXPERIMENTAL PROCEDURES
Animals
All animal experiments were carried out in accordance with the guidelines of
the Institutional Animal Care and Use Committee of the Salk Institute. The
feeding regimen experiments were repeated on four independent batches of
mice, and representative data sets are presented here. Whole-body indirect
calorimetry was carried out on a subset of mice at 4, 8, or 12 weeks, and all
other measurements were carried out on a subset of mice at least 12 weeks
after the initiation of the feeding regimens.
Feeding Schedule and Diets
Eight-week-old male C57BL/6J mice from Jackson Laboratory were group
housed (three to five mice per cage) under a 12 hr light:12 hr dark schedule
for 4 weeks to adapt to the housing condition. They were fed NC (LabDiet
5001; 29% protein, 13% fat, 58% carbohydrates) or HFD (LabDiet 58Y1;
18% protein, 61% fat, 21% carbohydrates) either with unrestricted (ad lib) or
temporally restricted access to food (tRF) (see Figure 1A). Under tRF, mice
were allowed access to food between ZT13 (1 hr after lights off) and ZT21
(3 hr before lights on). Food access was regulated by transferring mice daily
between cages with food and water and cages with water only. To control
for mouse handling, ad lib-fed mice were also transferred between feeding
cages at the same time. Weekly food intake was measured by monitoring
the weight of the remaining food.
Metabolic Cages
Whole-body metabolic states were tested by indirect calorimetry in a CLAMS
system (Columbus Instruments) for 2 days after 4 days of habituation following
the manufacturer’s instructions. Light and feeding conditions were kept the
same as in the home cages.
Glucose Tolerance
Mice were fasted for 16 hr, and fasted glucose wasmeasured using a Glucom-
eter (One Touch Ultra) by tail bleeds. Subsequently, mice were intraperitone-
ally injected with 1 g glucose/kg of body weight, and blood glucose was
measured in intervals of 30 min for 2 hr.(B) A summary of metabolite changes in the liver highlights the larger effect of tem
eight time points for each feeding regimenwere treated as replicates. Number of m
in the right panel.
(C–E) (C) Heatmap rendering of a subset of metabolites of a cluster enriched fo
anabolic metabolism. Tissues were harvested at ZT14, ZT17, ZT20, ZT23, ZT2, Z
high; green, low. Steady-state levels of several of the metabolites at eight differen
text are shown in (E). Normalized values presented in Table S1 are plotted again
858 Cell Metabolism 15, 848–860, June 6, 2012 ª2012 Elsevier Inc.Insulin and Leptin ELISAs
Overnight fasted mice were intraperitoneally injected with 1 g of glucose per
kilogram of body weight, and retro-orbital blood was collected after 1 hr.
Insulin (Crystal Chem #90080) and leptin (Millipore) ELISAs were measured
in the blood of fasted and glucose-injected mice following manufacturer’s
instructions.
ALT and Cholesterol
Mice were fasted for 16 hr starting from ZT21, and blood was collected retro-
orbitally. ALT and cholesterol were assayed by IDEXX Laboratories.
Rotarod
Mice were placed on accelerating (10—70 rpm) rotarods for up to 180 s. Mice
were tested on two subsequent days. On the first day, the mice were given five
trial runs for habituation. Data were collected from three runs on the second
day after two trials runs.
Histology and Electron Microscopy
Sections (6 mm) of formaldehyde-fixed liver, WAT, and BAT were stained with
H&E. Liver sections were also stained using Sirius red method. See the
Supplemental Information for details.
Body Composition
Body fat and lean mass of live mice were assessed using a mouse MRI (Echo
Medical Systems) following manufacturer’s protocol.
Transcript, Protein, and Metabolite Analyses
Three to four mice in each feeding groupwere sacrificed every 3 hr over a 24 hr
period, and individual liver, WAT, and BAT samples were flash frozen. Aliquots
of frozen tissues were used for immunoblot and qRT-PCR analyses carried out
as described earlier (Vollmers et al., 2009). Frozen liver aliquots were analyzed
for detection and relative quantification of metabolites by Metabolon following
published methods (Evans et al., 2009).
Statistical Tests
To account for diurnal variations in liver metabolites, samples collected at eight
different time points throughout the day were analyzed and treated as repli-
cates in ANOVA tests. For a given metabolite, the measured levels across all
samples were median normalized to 1, and missing data points (if any) were
imputed with the minimum values. Results were plotted in whisker plots where
the box denotes the middle 80 percentile with mean (+) and median (). Error
bars denote maximum and minimum of distribution with extreme data points
marked (o). The relative levels of all detected metabolites, changes in different
feeding groups, and the associated statistical test results are presented in
Table S1. Metabolic cage data, body weight, food consumed, and qRT-PCR
results were analyzed by Student’s t test (one tailed or two tailed based on
sample types). Only in cases where the average values appear close, signifi-
cant differences at p < 0.05 are denoted with ‘‘*.’’ Average (+SEM) values
are shown in the figures.SUPPLEMENTAL INFORMATION
Supplemental Information includes seven figures, two tables, Supplemental
Experimental Procedures, and Supplemental References and can be found
with this article at doi:10.1016/j.cmet.2012.04.019.poral feeding pattern when animals were fed HFD. For statistical analyses, all
etabolites that changed between any two of the six different contrasts is shown
r fatty acids and (D) another cluster enriched for intermediates of energy and
T5, ZT8, and ZT11. The time of food access is indicated in yellow boxes. Red,
t time points representing one full day from (C) and (D) marked with underlined
st time.
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